Search research articles
Contact Us
Filters
Showing results (51-60 of 1,133) with videos related to
Page
of 114
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
December 13, 2006
[Rheumatoid arthritis and osteoporosis: trends in their treatments]
Yoshiya Tanaka
Internal Medicine (Tokyo, Japan)
|
August 21, 2007
Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases
Yoshiya Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
December 17, 2008
[Immunosuppressive mechanisms in diabetes mellitus]
Yoshiya Tanaka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
January 20, 2009
[Paradigm shift in the therapy for rheumatoid arthritis and osteoporosis]
Yoshiya Tanaka
RMD Open
|
August 19, 2023
Viewpoint on anifrolumab in patients with systemic lupus erythematosus and a high unmet need in clinical practice
Yoshiya Tanaka
The Korean Journal of Internal Medicine
|
March 3, 2016
Current concepts in the management of rheumatoid arthritis
Yoshiya Tanaka
Clinical Calcium
|
March 8, 2018
[Homeostasis and Disorder of Musculoskeletal System.Progress in the treatment of rheumatoid arthritis.]
Yoshiya Tanaka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
May 25, 2012
[Programs for continuing medical education: A session; 8. Practice of rheumatoid arthritis]
Yoshiya Tanaka
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
September 27, 2016
[Neuropsychiatric Systemic Lupus Erythematosus]
Yoshiya Tanaka
Modern Rheumatology
|
June 13, 2020
A review of upadacitinib in rheumatoid arthritis
Yoshiya Tanaka
Page
of 114
Search research articles
Search
Showing results (51-60 of 1,133) with videos related to
Sort By:
Page
of 114
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
December 13, 2006
[Rheumatoid arthritis and osteoporosis: trends in their treatments]
Yoshiya Tanaka
Internal Medicine (Tokyo, Japan)
|
August 21, 2007
Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases
Yoshiya Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
December 17, 2008
[Immunosuppressive mechanisms in diabetes mellitus]
Yoshiya Tanaka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
January 20, 2009
[Paradigm shift in the therapy for rheumatoid arthritis and osteoporosis]
Yoshiya Tanaka
RMD Open
|
August 19, 2023
Viewpoint on anifrolumab in patients with systemic lupus erythematosus and a high unmet need in clinical practice
Yoshiya Tanaka
The Korean Journal of Internal Medicine
|
March 3, 2016
Current concepts in the management of rheumatoid arthritis
Yoshiya Tanaka
Clinical Calcium
|
March 8, 2018
[Homeostasis and Disorder of Musculoskeletal System.Progress in the treatment of rheumatoid arthritis.]
Yoshiya Tanaka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine
|
May 25, 2012
[Programs for continuing medical education: A session; 8. Practice of rheumatoid arthritis]
Yoshiya Tanaka
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
September 27, 2016
[Neuropsychiatric Systemic Lupus Erythematosus]
Yoshiya Tanaka
Modern Rheumatology
|
June 13, 2020
A review of upadacitinib in rheumatoid arthritis
Yoshiya Tanaka
Page
of 114